Drug · DIN 02401835
GENOTROPIN
MINIQUICK PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 18, 2013; first marketed September 18, 2013.
- Drug Identification Number (DIN)
- 02401835
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Powder For Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Somatropin H01AC01
- Class
- Human
- Record last updated
- September 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SOMATROPIN | 2 MG | SYR |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 7, 2013: NOC 14079Supplement to a New Drug Submission (SNDS) · Chemistry & manufacturing updates; New strengths.presentations; new indications for children; revised indication for adults
Other DINs named GENOTROPIN
- DIN 02401703 · Marketed
- DIN 02401711 · Marketed
- DIN 02401746 · Marketed
- DIN 02401754 · Marketed
- DIN 02401762 · Marketed
- DIN 02401770 · Marketed
- DIN 02401789 · Marketed
- DIN 02401797 · Marketed
- DIN 02401800 · Marketed
- DIN 02401819 · Marketed
- DIN 02401827 · Marketed
- DIN 02401681 · Approved